nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—ADRB3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0297	0.0297	CbGpPWpGaD
Alprenolol—HTR1A—Serotonin receptors—HTR2A—narcolepsy	0.0225	0.0225	CbGpPWpGaD
Alprenolol—ADRB3—G alpha (s) signalling events—P2RY11—narcolepsy	0.0217	0.0217	CbGpPWpGaD
Alprenolol—ADRB1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0176	0.0176	CbGpPWpGaD
Alprenolol—ADRB3—Monoamine GPCRs—HTR2A—narcolepsy	0.0176	0.0176	CbGpPWpGaD
Alprenolol—ADRB2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0173	0.0173	CbGpPWpGaD
Alprenolol—HTR1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0169	0.0169	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Other—P2RY11—narcolepsy	0.0161	0.0161	CbGpPWpGaD
Alprenolol—ADRB3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0148	0.0148	CbGpPWpGaD
Alprenolol—ADRB1—G alpha (s) signalling events—P2RY11—narcolepsy	0.0129	0.0129	CbGpPWpGaD
Alprenolol—ADRB2—G alpha (s) signalling events—P2RY11—narcolepsy	0.0126	0.0126	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0121	0.0121	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Alprenolol—ADRB1—Monoamine GPCRs—HTR2A—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Alprenolol—ADRB2—Monoamine GPCRs—HTR2A—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Alprenolol—ADRB3—G alpha (s) signalling events—NPS—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Alprenolol—HTR1A—Monoamine GPCRs—HTR2A—narcolepsy	0.01	0.01	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0088	0.0088	CbGpPWpGaD
Alprenolol—ADRB1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00879	0.00879	CbGpPWpGaD
Alprenolol—ADRB2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0086	0.0086	CbGpPWpGaD
Alprenolol—HTR1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00841	0.00841	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—HCRTR2—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—HCRTR1—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—P2RY11—narcolepsy	0.00788	0.00788	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00784	0.00784	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00742	0.00742	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00742	0.00742	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00717	0.00717	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0071	0.0071	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0071	0.0071	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00701	0.00701	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00685	0.00685	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00682	0.00682	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—HCRT—narcolepsy	0.0067	0.0067	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00667	0.00667	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00636	0.00636	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00636	0.00636	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00622	0.00622	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00614	0.00614	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00608	0.00608	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00608	0.00608	CbGpPWpGaD
Alprenolol—ADRB1—G alpha (s) signalling events—NPS—narcolepsy	0.00603	0.00603	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00601	0.00601	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—PENK—narcolepsy	0.00597	0.00597	CbGpPWpGaD
Alprenolol—ADRB2—G alpha (s) signalling events—NPS—narcolepsy	0.0059	0.0059	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00587	0.00587	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00585	0.00585	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—PENK—narcolepsy	0.0056	0.0056	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00522	0.00522	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00511	0.00511	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—TRH—narcolepsy	0.00508	0.00508	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00499	0.00499	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HCRTR1—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HCRTR2—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0048	0.0048	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.00474	0.00474	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.00474	0.00474	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.00468	0.00468	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00465	0.00465	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00463	0.00463	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00463	0.00463	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00461	0.00461	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00461	0.00461	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.00457	0.00457	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—P2RY11—narcolepsy	0.00447	0.00447	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—P2RY11—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—HRH3—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HCRTR2—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HCRTR1—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—HRH3—narcolepsy	0.00417	0.00417	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—P2RY11—narcolepsy	0.00404	0.00404	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.00398	0.00398	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00396	0.00396	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00396	0.00396	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00389	0.00389	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HCRT—narcolepsy	0.0038	0.0038	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HCRT—narcolepsy	0.00379	0.00379	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—TAC1—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—NPS—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00354	0.00354	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HCRT—narcolepsy	0.00344	0.00344	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—PENK—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—PENK—narcolepsy	0.00337	0.00337	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PENK—narcolepsy	0.00306	0.00306	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.00301	0.00301	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—TRH—narcolepsy	0.00288	0.00288	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—TRH—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.00264	0.00264	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—TRH—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HRH3—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HRH3—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HCRTR2—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HCRTR1—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.0024	0.0024	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—P2RY11—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—P2RY11—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HRH3—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—HTR2A—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HCRT—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—TAC1—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—NPS—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—TAC1—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—NPS—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HCRT—narcolepsy	0.00203	0.00203	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00202	0.00202	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.002	0.002	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.002	0.002	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HCRT—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PENK—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—NPS—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—TAC1—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PENK—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PENK—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—TRH—narcolepsy	0.00163	0.00163	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TRH—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TRH—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HRH3—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HCRTR2—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HCRTR1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HRH3—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—P2RY11—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HRH3—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HRH3—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HTR2A—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HTR2A—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—NPS—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HCRT—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—TAC1—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—NPS—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HCRT—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR2A—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TAC1—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—NPS—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NPS—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TAC1—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TAC1—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—NPS—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PENK—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PENK—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PENK—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CHKB—narcolepsy	0.000977	0.000977	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TRH—narcolepsy	0.000913	0.000913	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TRH—narcolepsy	0.000894	0.000894	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TRH—narcolepsy	0.000874	0.000874	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HRH3—narcolepsy	0.000801	0.000801	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.000783	0.000783	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HRH3—narcolepsy	0.000766	0.000766	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	0.000744	0.000744	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.000728	0.000728	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000712	0.000712	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	0.000676	0.000676	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2A—narcolepsy	0.000673	0.000673	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000664	0.000664	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TAC1—narcolepsy	0.000664	0.000664	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NPS—narcolepsy	0.000664	0.000664	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.000661	0.000661	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.000649	0.000649	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NPS—narcolepsy	0.000649	0.000649	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2A—narcolepsy	0.000646	0.000646	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TAC1—narcolepsy	0.000635	0.000635	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NPS—narcolepsy	0.000635	0.000635	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—narcolepsy	0.000399	0.000399	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000391	0.000391	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—narcolepsy	0.000382	0.000382	CbGpPWpGaD
